severe emphysema

October 14, 2016October 14, 2016

Pivotal Clinical Trial of Zephyr Endobronchial Valve for Emphysema Completes Enrollment

News

Pulmonx announced that patient enrollment is complete for its pivotal investigational device exemption (IDE) study of the Zephyr Endobronchial Valve (EBV) for the treatment of severe emphysema. Results from the randomized, multi-center LIBERATE clinical ... Read more

April 11, 2016April 11, 2016

Segmental Vapor Ablation for Emphysema Improves Patients’ Pulmonary Function, Researchers Find

Emphysema, News

In a new study, researchers investigated whether selective treatment with vapor ablation of the more diseased lobe segments in the lungs led to clinical improvements in patients suffering from severe ... Read more

March 21, 2016March 21, 2016

Experts Recommend Zephyr EBV as Only Minimally Invasive Emphysema Treatment for Use Outside Clinical Trials

Emphysema, News

Pulmonx, based in Redwood City, California, recently announced the publication of recommendations from a panel of experts offering broad guidance regarding selection of therapies for patients with advanced emphysema. The panel recommended that only ... Read more